Zsuzsanna Kovacs

Dr. Zsuzsanna Kovacs

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2013 in Fungal Genetics and Biology
Verified
Journal Article
Closed access
ZKZsuzsanna Kovacs
Zsuzsanna Kovacs
MSMáté Szarka
Máté Szarka
SKSzilvia Kovács
Szilvia Kovács
IBImre Boczonádi
Imre Boczonádi
TETamás Emri
Tamás Emri
TPTünde Pusztahelyi
Tünde Pusztahelyi

1 January 2020 in Journal of Chromatography B
Verified
Journal Article
Open access
BMBrigitta Mészáros
Brigitta Mészáros
GJGábor Járvás
Gábor Járvás
AFAnna Farkas
Anna Farkas
MSMárton Szigeti
Márton Szigeti
ZKZsuzsanna Kovacs
Zsuzsanna Kovacs
Andras GuttmanAndras Guttman
Andras Guttman
Lung cancer (LC) and chronic obstructive pulmonary disease (COPD) are prevalent ailments with a great challenge to distinguish them based on symptoms only. Since they require different treatments, it is important to find non-invasive methods capable to readily diagnose them. Moreover, COPD increases the risk of lung cancer development, leading to their comorbidity. In this pilot study the N-glycosylation profile of pooled human serum samples (90 patients each) from lung cancer, COPD and comorbidity (LC with COPD) patients were investigated in comparison to healthy individuals (control) by capillary gel electrophoresis with high sensitivity laser-induced fluorescence detection. Sample preparation was optimized for human serum samples introducing a new temperature adjusted denaturation protocol to prevent precipitation and increased endoglycosidase digestion time to assure complete removal of the N-linked carbohydrates. The reproducibility of the optimized method was 33% in relative peak areas) between the pathological and control samples. In addition to N-glycan profile changes, alterations in the individual N-glycan subclasses, such as total fucosylation, degree of sialylation and branching may also hold important glycobiomarker values.

21 February 2017 in Electrophoresis
Verified
Journal Article
Closed access
PDF file
ZKZsuzsanna Kovacs
Zsuzsanna Kovacs
ASAdam Simon
Adam Simon
ZSZoltan Szabo
Zoltan Szabo
ZNZsolt Nagy
Zsolt Nagy
LVLaszlo Varoczy
Laszlo Varoczy
Andras GuttmanAndras Guttman
Andras Guttman

1 September 2016 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
ZKZsuzsanna Kovacs
Zsuzsanna Kovacs
MSMáté Szarka
Máté Szarka
MSMárton Szigeti
Márton Szigeti
Andras GuttmanAndras Guttman
Andras Guttman

1 August 2017 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
ZKZsuzsanna Kovacs
Zsuzsanna Kovacs
GPGábor Papp
Gábor Papp
HHHenrietta Horváth
Henrietta Horváth
FJFerenc Joó
Ferenc Joó
Andras GuttmanAndras Guttman
Andras Guttman

Verified
Journal Article
Open access
PDF file
Enikő GebriEnikő Gebri
Enikő Gebri
ZKZsuzsanna Kovacs
Zsuzsanna Kovacs
BMBrigitta Mészáros
Brigitta Mészáros
TFTóth Ferenc
Tóth Ferenc
ASAdam Simon
Adam Simon
THTibor Hortobágyi
Tibor Hortobágyi
Background: Oral and enteral mucositis due to high-dose cytostatic treatment administered during autologous and allogeneic stem-cell transplantation increases mortality. Salivary secretory immunoglobulin A (sIgA) is a basic pillar of local immunity in the first line of defense. Altered salivary sialoglycoprotein carbohydrates are important in the pathologies in the oral cavity including inflammation, infection and neoplasia. Therefore, we assessed whether changes in the salivary and serum IgA glycosylation correlated with development and severity of oral mucositis. Methods: Using capillary electrophoresis, comparative analysis of serum and salivary IgA total N-glycans was conducted in 8 patients with autologous peripheral stem-cell transplantation (APSCT) at four different stages of transplantation (day −3/−7, 0, +7, +14) and in 10 healthy controls. Results: Fourteen out of the 31 structures identified in serum and 6 out of 38 in saliva showed significant changes upon transplantation compared with the control group. Only serum core fucosylated, sialylated bisecting biantennary glycan (FA2BG2S2) showed significant differences between any two stages of transplantation (day −3/−7 and day +14; p = 0.0279). Conclusion: Our results suggest that changes in the serum IgA total N-glycan profile could serve as a disease-specific biomarker in patients undergoing APSCT, while analysis of salivary IgA N-glycan reflects the effect of APSCT on local immunity.